UK markets close in 4 hours 51 minutes

PW Medtech Group Limited (PWE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1100+0.0110 (+11.11%)
As of 08:05AM CEST. Market open.

PW Medtech Group Limited

Building 1
No. 23 Panlong West Road Pinggu District
Beijing 101204
China

https://www.pwmedtech.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees1,244

Key executives

NameTitlePayExercisedYear born
Ms. Yue'e ZhangExecutive Chairman & CEO129.84kN/A1963
Ms. Tian TianFinancial DirectorN/AN/A1982
Ms. Ka Man So A.C.I.S., A.C.S., FCIS, FCSCompany SecretaryN/AN/A1974
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices, high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, and hemoperfutors; and animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Corporate governance

PW Medtech Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.